- Pagina principale
- Analisi dell'app gratuita
- CURB-65 Score for Pneumonia
CURB-65 Score for Pneumonia analisi dell'app per 7 dicembre
CURB-65 Score for Pneumonia
- Putu Angga Risky Raharja
- App Store di Apple
- Gratis
- Settore Medico
CURB-65 Score for Pneumonia is a medical app designed to help medical practitioner to estimates 30-day mortality risk of community-acquired pneumonia (CAP) so they can decide inpatient vs. outpatient treatment. CURB-65, also known as the CURB criteria, is a clinical prediction rule that has been validated for predicting mortality in community-acquired pneumonia (CAP) and infection of any site. The score is an acronym for each of the risk factors measured. Each risk factor scores one point, for a maximum score of 5:
* Confusion of new onset (defined as an AMTS of 8 or less)
* Blood Urea nitrogen greater than 7 mmol/l (19 mg/dL)
* Respiratory rate of 30 breaths per minute or greater
* Blood pressure less than 90 mmHg systolic or diastolic blood pressure 60 mmHg or less
* Age 65 or older
All calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for clinical judgment. Calculations in this app might be different with your local practice. Consult to expert doctor whenever necessary. Please seek a doctor’s advice in addition to using this app and before making any medical decisions.
Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1746657/?tool=pmcentrez
Classifica degli store
La classifica del store si basa su diversi parametri stabiliti da Google e Apple.
Tutte le categorie in
Stati Uniti--
Settore Medico in
Stati Uniti--
Crea un account per visualizzare il numero mensile medio di downloadContattaci
CURB-65 Score for PneumoniaStatistiche di ranking nel tempo
Classifica di Utilizzo di Similarweb e Classifica App Store di Apple per CURB-65 Score for Pneumonia
Rank
Nessun dato disponibile
CURB-65 Score for Pneumonia Classifica per paese
Paesi in cui CURB-65 Score for Pneumonia ha la posizione più alta nelle sue categorie principali
Nessun dato da visualizzare
Principali concorrenti e app alternative
App con un'alta probabilità di essere utilizzate dagli stessi utenti, provenienti dallo stesso store.
SEPSIS 3
ScyMed, Inc
NIHSS Records
Beijing Fate Med Technology Co., Ltd.
CV Risk Estimation
United Health Services, Inc.
Family Practice Guideline
Skyscape Medpresso Inc
7icembre d, 2025